المؤلفون: F. Hitz, M. Kraus, T. Pabst, D. Hess, L. Besse, T. Silzle, U. Novak, K. Seipel, S. Rondeau, S. Stüdeli, S. Berardi Vilei, P. Samaras, U. Mey, C. Driessen, for the Swiss Group for Clinical Cancer Research SAKK

المصدر: Blood Cancer Journal, Vol 9, Iss 9, Pp 1-8 (2019)
Hitz, F; Kraus, M; Pabst, Thomas; Hess, D; Besse, L; Silzle, T; Novak, Urban; Seipel, Katja; Rondeau, S; Stüdeli, S; Vilei, S Berardi; Samaras, P; Mey, U; Driessen, C (2019). Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10). Blood cancer journal, 9(9), p. 70. Springer Nature 10.1038/s41408-019-0228-2 <http://dx.doi.org/10.1038/s41408-019-0228-2>
Blood Cancer Journal

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Cell biology, Anti-Inflammatory Agents, 610 Medicine & health, Peripheral blood mononuclear cell, Gastroenterology, lcsh:RC254-282, Article, Dexamethasone, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Adverse effect, Lenalidomide, Multiple myeloma, Pneumonitis, Aged, Aged, 80 and over, Nelfinavir, business.industry, Bortezomib, Hematology, HIV Protease Inhibitors, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cancer therapeutic resistance, Oncology, 030220 oncology & carcinogenesis, Female, business, Multiple Myeloma, 030215 immunology, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b09dcc16e1fd8629234b44651d327686
http://link.springer.com/article/10.1038/s41408-019-0228-2

المؤلفون: Hitz F; Department of Oncology and Hematology, Kantonsspital St.Gallen, St.Gallen, Switzerland. felicitas.hitz@kssg.ch., Kraus M; Department of Oncology and Hematology, Kantonsspital St.Gallen, St.Gallen, Switzerland., Pabst T; Department of Medical Oncology, Inselspital, Universitätsspital Bern, Bern, Switzerland., Hess D; Department of Oncology and Hematology, Kantonsspital St.Gallen, St.Gallen, Switzerland., Besse L; Department of Oncology and Hematology, Kantonsspital St.Gallen, St.Gallen, Switzerland., Silzle T; Department of Oncology and Hematology, Kantonsspital St.Gallen, St.Gallen, Switzerland., Novak U; Department of Medical Oncology, Inselspital, Universitätsspital Bern, Bern, Switzerland., Seipel K; Department of Medical Oncology, Inselspital, Universitätsspital Bern, Bern, Switzerland., Rondeau S; SAKK Coordinating Center, Bern, Switzerland., Stüdeli S; SAKK Coordinating Center, Bern, Switzerland., Vilei SB; SAKK Coordinating Center, Bern, Switzerland., Samaras P; Hirslanden, Zürich, Switzerland., Mey U; Department of Oncology, Kantonsspital Graubünden, Chur, Switzerland., Driessen C; Department of Oncology and Hematology, Kantonsspital St.Gallen, St.Gallen, Switzerland.

مؤلفون مشاركون: Swiss Group for Clinical Cancer Research SAKK

المصدر: Blood cancer journal [Blood Cancer J] 2019 Aug 27; Vol. 9 (9), pp. 70. Date of Electronic Publication: 2019 Aug 27.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Inflammatory Agents/*therapeutic use , Dexamethasone/*therapeutic use , HIV Protease Inhibitors/*therapeutic use , Lenalidomide/*therapeutic use , Multiple Myeloma/*drug therapy , Nelfinavir/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Anti-Inflammatory Agents/pharmacology ; Dexamethasone/pharmacology ; Female ; HIV Protease Inhibitors/pharmacology ; Humans ; Lenalidomide/pharmacology ; Male ; Middle Aged ; Multiple Myeloma/pathology ; Nelfinavir/pharmacology

المؤلفون: Pensalfini M; Institute for Mechanical Systems, Department of Mechanical and Process Engineering, ETH Zurich, Leonhardstrasse 21, 8092 Zurich, Switzerland., Ehret AE; Institute for Mechanical Systems, Department of Mechanical and Process Engineering, ETH Zurich, Leonhardstrasse 21, 8092 Zurich, Switzerland; Empa, Swiss Federal Laboratories for Materials Science and Technology, Überlandstrasse 129, 8600 Dübendorf, Switzerland., Stüdeli S; Tissue Biology Research Unit, Department of Surgery, University Children's Hospital Zurich, August-Forel-Strasse 7, 8008 Zurich, Switzerland., Marino D; Tissue Biology Research Unit, Department of Surgery, University Children's Hospital Zurich, August-Forel-Strasse 7, 8008 Zurich, Switzerland., Kaech A; Center for Microscopy and Image Analysis, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland., Reichmann E; Tissue Biology Research Unit, Department of Surgery, University Children's Hospital Zurich, August-Forel-Strasse 7, 8008 Zurich, Switzerland., Mazza E; Institute for Mechanical Systems, Department of Mechanical and Process Engineering, ETH Zurich, Leonhardstrasse 21, 8092 Zurich, Switzerland; Empa, Swiss Federal Laboratories for Materials Science and Technology, Überlandstrasse 129, 8600 Dübendorf, Switzerland.

المصدر: Journal of the mechanical behavior of biomedical materials [J Mech Behav Biomed Mater] 2017 May; Vol. 69, pp. 85-97. Date of Electronic Publication: 2016 Dec 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101322406 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0180 (Electronic) Linking ISSN: 18780180 NLM ISO Abbreviation: J Mech Behav Biomed Mater Subsets: MEDLINE

مواضيع طبية MeSH: Skin, Artificial* , Tissue Engineering*, Collagen/*analysis , Hydrogels/*analysis, Biocompatible Materials/analysis ; Biomechanical Phenomena ; Fibroblasts ; Humans ; Skin ; Stress, Mechanical